Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 2.8B | 2.6B | 2.6B |
Cost of revenue | 1.2B | 1.4B | 1.2B | 1.2B |
Gross profit | 1.4B | 1.4B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 42M | 48M | 43M | 47M |
Other operating expenses | 129M | 155M | 142M | 122M |
Operating income | 632M | 555M | 616M | 620M |
Non operating interest income | ||||
Income | 11M | 10M | 8M | 7M |
Expense | 122M | 119M | 118M | 119M |
Other income expense | — | — | — | — |
Pretax income | 500M | 428M | 487M | 483M |
Tax provision | 129M | 107M | 121M | 127M |
Net income | 371M | 321M | 366M | 356M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 7.8B | 7.8B | 7.8B | 7.8B |
Diluted average shares | 7.8B | 7.8B | 7.8B | 7.8B |
EBITDA | 1.1B | 1.0B | 1.1B | 1.1B |
Net income from continuing op. | 371M | 321M | 366M | 356M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |